Singapore HSA registration DE0510693

Siemens Atellica IM DHEAS2

Singapore flagSingapore·CLASS B IVD·Siemens Healthcare Diagnostics Inc·Registered May 07, 2025
Device classification
Device Class
CLASS B IVD
Medical Speciality Area
Immunology
Registration information
Registration Number
DE0510693
Registration Date
May 07, 2025
Retention Due Date
May 06, 2026
Product description
The Atellica® IM DHEAS2 assay is for in vitro diagnostic use in the quantitative determination of DHEAS in human serum and plasma (EDTA and lithium heparin) using the Atellica® Analyzer. Measurements of DHEAS are used in the evaluation of adrenal gland function and as an aid in the diagnosis of disorders associated with the adrenal glands.
Product Owner
Short Name
Siemens Healthcare
Address
511 Benedict Avenue, Tarrytown, NY 10591-5097, UNITED STATES
Registrant
Address
60 MACPHERSON ROAD, THE SIEMENS CENTRE, SINGAPORE 348615
Importer
Address
60 MACPHERSON ROAD, THE SIEMENS CENTRE, SINGAPORE 348615
Model information
Model Name(s)
Atellica IM Multi‑Diluent 3 Atellica IM DHEAS2 Atellica IM DHEAS2 MCM
Model Identifier(s)
10995645 11209193 11209195
About this record

Access comprehensive regulatory information for Siemens Atellica IM DHEAS2 in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0510693 and owned by Siemens Healthcare Diagnostics Inc. The device was registered on May 07, 2025.

This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.

Free DatabasePowered by Pure Global AIHSA Official DataCLASS B IVD